Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ross Terres JA"'
Autor:
Rovin BH; The Ohio State University Wexner Medical Center, Columbus., Furie RA; Northwell Health, Great Neck, New York., Ross Terres JA; Genentech, Inc, South San Francisco, California., Giang S; Genentech, Inc, South San Francisco, California., Schindler T; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Turchetta A; Hoffmann-La Roche Ltd, Mississauga, Ontario, Canada., Garg JP; Genentech, Inc, South San Francisco, California., Pendergraft WF 3rd; Genentech, Inc, South San Francisco, California., Malvar A; Hospital Fernandez, Buenos Aires, Argentina.
Publikováno v:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2024 Feb; Vol. 76 (2), pp. 247-254. Date of Electronic Publication: 2023 Nov 10.
Autor:
Bieber T; Department of Dermatology and Allergy, University Medical Center, Bonn, Germany.; Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland., Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Kabashima K; Department Dermatology, Kyoto University School of Medicine, Kyoto, Japan., Feely M; Eli Lilly and Company, Indianapolis, IN, USA.; Department of Dermatology, Mount Sinai Hospital, New York, NY, USA., Rueda MJ; Eli Lilly and Company, Indianapolis, IN, USA., Ross Terres JA; Eli Lilly and Company, Indianapolis, IN, USA., Wollenberg A; Department of Dermatology and Allergy, University Hospital, Ludwig Maximillian University, Munich, Germany.; Department of Dermatology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Sep; Vol. 36 (9), pp. 1432-1449.
Autor:
Dörner T; Department of Medicine and Department of Rheumatology and Clinical Immunology, Charite Universitatsmedizin Berlin and Deutsches Rheumaforschungszentrum (DRFZ), Berlin, Germany thomas.doerner@charite.de., Tanaka Y; First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan., Dow ER; Eli Lilly and Company, Indianapolis, Indiana, USA., Koch AE; Eli Lilly and Company, Indianapolis, Indiana, USA., Silk M; Eli Lilly and Company, Indianapolis, Indiana, USA., Ross Terres JA; Eli Lilly and Company, Indianapolis, Indiana, USA., Sims JT; Eli Lilly and Company, Indianapolis, Indiana, USA., Sun Z; Eli Lilly and Company, Indianapolis, Indiana, USA., de la Torre I; Eli Lilly and Company, Indianapolis, Indiana, USA., Petri M; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2022 Aug 11; Vol. 81 (9), pp. 1267-1272. Date of Electronic Publication: 2022 Aug 11.
Autor:
Bello N; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA. bello_natalia@lilly.com., Birt JA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Workman J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Zhou X; Syneos Health, Morrisville, USA., Ross-Terres JA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, 46285, USA., Petri M; Johns Hopkins University School of Medicine, Baltimore, USA.
Publikováno v:
Advances in therapy [Adv Ther] 2022 Jul; Vol. 39 (7), pp. 3131-3145. Date of Electronic Publication: 2022 May 09.
Autor:
Dörner T; Department Medicine/Rheumatology and Clinical Immunology, Charite - Universitätsmedizin Berlin and Deutsches Rheuma-Forschungszentrum (DRFZ), Chariteplatz, 01 10117, Berlin, Germany. thomas.doerner@charite.de., van Vollenhoven RF; University Medical Center, Amsterdam, The Netherlands., Doria A; University of Padova, Padova, Italy., Jia B; Eli Lilly and Company, Indianapolis, IN, USA., Ross Terres JA; Eli Lilly and Company, Indianapolis, IN, USA., Silk ME; Eli Lilly and Company, Indianapolis, IN, USA., de Bono S; Eli Lilly and Company, Indianapolis, IN, USA., Fischer P; Eli Lilly and Company, Indianapolis, IN, USA., Wallace DJ; Cedars-Sinai Medical Center and University of California at Los Angeles, Los Angeles, CA, USA.
Publikováno v:
Arthritis research & therapy [Arthritis Res Ther] 2022 May 16; Vol. 24 (1), pp. 112. Date of Electronic Publication: 2022 May 16.
Autor:
Reich K; Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Skinflammation® Center, Hamburg and Dermatologikum Berlin, Berlin, Germany., DeLozier AM; Eli Lilly and Company, Indianapolis, IN, USA., Nunes FP; Eli Lilly and Company, Indianapolis, IN, USA., Thyssen JP; Department of Dermatology and Allergy, Herlev and Gentofte Hospital and University of Copenhagen, Copenhagen, Denmark., Eichenfield LF; Departments of Dermatology and Pediatrics, University of California, San Diego and Rady Children's Hospital, San Diego, CA, USA., Wollenberg A; Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany., Ross Terres JA; Eli Lilly and Company, Indianapolis, IN, USA., Watts SD; Eli Lilly and Company, Indianapolis, IN, USA., Chen YF; Eli Lilly and Company, Indianapolis, IN, USA., Simpson EL; Department of Dermatology, Oregon Health and Science University, Portland, OR, USA., Silverberg JI; Department of Dermatology, George Washington University School of Medicine, Washington, DC, USA.
Publikováno v:
The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1521-1530. Date of Electronic Publication: 2020 Nov 22.
Autor:
Urowitz MB; M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; m.urowitz@utoronto.ca., Gladman DD; M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada., Ibañez D; M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada., Su J; M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada., Mursleen S; S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada., Sayani A; S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada., Ross Terres JA; S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada.; J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA., Iczkovitz S; S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada.
Publikováno v:
The Journal of rheumatology [J Rheumatol] 2021 Jan 01; Vol. 48 (1), pp. 67-73. Date of Electronic Publication: 2020 Apr 01.
Autor:
Lio PA, Wollenberg A, Thyssen JP, Pierce EJ, Rueda MJ, DeLozier AM, Ross Terres JA, Anderson P, Milligan G, Piercy J, Silverberg JI, Paul C
Publikováno v:
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 Oct 01; Vol. 19 (10), pp. 943-948.
Autor:
Gipson DS; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA., Hladunewich MA; Department of Internal Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Lafayette R; Department of Internal Medicine, Stanford University, Stanford, California, USA., Sedor JR; Department of Internal Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Rovin BH; Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Barbour SJ; Department of Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada., McMahon A; Department of Internal Medicine, University of Alberta Hospital, Edmonton, Alberta, Canada., Jennette JC; Department of Pathology, University of North Carolina, Chapel Hill, North Carolina, USA., Nachman PH; Department of Internal Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.; Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota, USA., Willette RN; PoC Pharma Consulting, LLC, Pottstown, Pennsylvania, USA., Paglione M; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Gao F; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Ross Terres JA; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Vallow S; Worldwide Clinical Trials, Morrisville, North Carolina, USA., Holland MC; Teva Pharmaceuticals, Frazer, Pennsylvania, USA., Thorneloe KS; GlaxoSmithKline, Collegeville, Pennsylvania, USA., Sprecher DL; BioView Consultants, LLC, Blue Bell, Pennsylvania, USA.
Publikováno v:
Kidney international reports [Kidney Int Rep] 2020 May 26; Vol. 5 (8), pp. 1228-1239. Date of Electronic Publication: 2020 May 26 (Print Publication: 2020).
Autor:
Ross Terres JA; GlaxoSmithKline, Mississauga, ON, Canada. Jorge.A.Ross@gsk.com.; GlaxoSmithKline, 2301 Renaissance Boulevard, King of Prussia, PA, 19406, USA. Jorge.A.Ross@gsk.com.; Center of Helth Economics, University of York, York, UK. Jorge.A.Ross@gsk.com., Lozano-Ortega G; GlaxoSmithKline, 2301 Renaissance Boulevard, King of Prussia, PA, 19406, USA. Greta.LozanoOrtega@iconplc.com.; Center of Helth Economics, University of York, York, UK. Greta.LozanoOrtega@iconplc.com., Kendall R; GlaxoSmithKline, 2301 Renaissance Boulevard, King of Prussia, PA, 19406, USA. Robyn.Kendall@iconplc.com.; Center of Helth Economics, University of York, York, UK. Robyn.Kendall@iconplc.com., Sculpher MJ; Oxford Outcomes Ltd, Vancouver, Canada. Mark.Sculpher@iconplc.com.; Center of Helth Economics, University of York, York, UK. Mark.Sculpher@iconplc.com.
Publikováno v:
BMC cardiovascular disorders [BMC Cardiovasc Disord] 2015 Dec 29; Vol. 15, pp. 180. Date of Electronic Publication: 2015 Dec 29.